AbbVie’s more than £120m (US$161m) investment will harness Oxford’s “leading life sciences ecosystem,” says Global Head of ...
CEO Albert Bourla describes Pfizer’s Q3 2026 results as demonstrating “strong momentum”, as the firm also appointed Cecile ...
This week’s top stories include Boehringer's digital patient twin ambitions, the Lancet’s climate change warning and NVIDIA’s ...
CEO Leonard Schleifer describes Q3 2026 as an “outstanding quarter” for Regeneron, as Dupixent, EYLEA HD and Libtayo each ...
The Lancet Countdown Report 2026 urges governments to treat climate change as a public health emergency as its impacts on ...
WPP UK CEO Kate Rowlinson describes the partnership with Cancer Research UK as a “privilege”, as the charity looks to ...
Deutsche Telekom's investment in Tandem Health aligns with its wider strategy to support innovation across AI, digital platforms and sovereign cloud infrastructure. Credit: Deutsche Telekom Tandem ...
GSK’s Hesham Abdullah says novel cancer treatments and drug development advances are “creating opportunities that simply ...
Swiss pharmaceutical company Acino is headquartered in Zurich and was founded in 1836. The company provides pharmaceuticals that are both affordable and of a high-quality which it supplies through ...
Global healthcare CEOs face rising demand, ESG gaps and supply risks, betting on AI and digitalisation while racing to build resilient, sustainable systems KPMG has released its 2025 Healthcare CEO ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results